Vcheck Blog: Due Diligence Insights for Private Equity
-
PACER Data Now Integrated into Vcheck’s Monitoring Providing Real-time Access to Federal Civil, Criminal, and Bankruptcy Filings June 11, 2025 Now monitoring PACER: Real-time alerts on federal court filings to catch legal risks as they unfold. -
Vcheck’s Monitoring Platform Is Transforming Financial Services Compliance June 11, 2025 Now live: PACER integration for real-time federal court monitoring—purpose-built for financial services compliance and risk management. -
Tackling the $3.1 Billion Corporate Fraud Problem with Continuous Monitoring June 6, 2025 Corporate fraud and white-collar crimes disrupt industries and erode public trust. -
Vcheck’s public records research uncovered partnership risks in former professional athlete May 21, 2025 When a leading private equity firm considered investing in a prominent former athlete’s business, Vcheck’s thorough investigation across 15+ jurisdictions uncovered critical red flags.. -
How FinCEN’s New AML/CFT Rule Reshapes Due Diligence for Investment Advisers May 1, 2025 Effective January 1, 2026, this rule closes a gap in financial oversight frameworks by classifying IAs as financial institutions under the Bank Secrecy Act (BSA). IAs will now face full AML/CFT compliance for the first time. -
ExThera Case Exposes Immediate Investor Threat Due to Poor Startup Due Diligence April 22, 2025 In January 2025, The New York Times published an exposé by John Carreyrou on ExThera Medical, a California startup that allegedly repurposed its FDA-authorized COVID-19 blood filter for cancer treatment without regulatory approval.